HyangWon (Harriet) Min is Vice President of Regulatory Affairs, Innovative Medicine, Asia Pacific. She is responsible for leading the regional regulatory affairs organization covering all therapeutic areas in the Asia Pacific region. She is also a member of the Global Regulatory Affairs Senior Leadership Team.
Harriet joined Janssen Korea in 2013 as Director of Regulatory Affairs and Business Quality, and she transitioned to the role of Senior Director, Regulatory & Medical Affairs for Janssen Korea in 2019. Under her leadership, the Medical Affairs, as well as the Regulatory Affairs and Commercial Quality teams, have been continuously recognized as high performing organizations using innovative approaches and strong cross-functional collaborations.
Prior to joining Janssen, Harriet gained extensive experience in the pharmaceutical and medical device industry, holding leadership roles in various functions including Regulatory Affairs, Pharmacovigilance, Market Access, and Quality Assurance. Prior to joining the pharmaceutical industry, Harriet served as a pharmacist for two years.
Harriet received her Bachelor of Science and Master of Science degrees in Pharmacy from Seoul National University, Seoul, South Korea.